lymphadenopathy uniba 18-1-13

Upload: wahyudi-yusman

Post on 03-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    1/34

    Approach to

    LymphadenopathyDr Putra Hendra SpPD

    UNIBA

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    2/34

    Definition

    Approx 600 LN in body

    LAN = abnl size,

    number, consistency

    Generalized vs Local

    Peripheral (central LAN

    presents differently)

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    3/34

    Lymph Nodes

    Anatomy

    Collection of lymphoid cells attached to both vascular and

    lymphatic systems

    Over 600 lymph nodes in the body Function

    To provide optimal sites for the concentration of free or cell-

    associated antigens and recirculating lymphocytes

    sensitization of the immune response To allow contact between B-cells, T-cells and macrophages

    Lymphadenopathy - node greater than 1cm in size

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    4/34

    Why do lymph nodes enlarge?

    Increase in the number of benign lymphocytesand macrophages in response to antigens

    Infiltration of inflammatory cells in infection

    (lymphadenitis) In situ proliferation of malignant lymphocytes or

    macrophages

    Infiltration by metastatic malignant cells Infiltration of lymph nodes by metabolite laden

    macrophages (lipid storage diseases)

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    5/34

    Definitions

    Pathologic Lymph Node

    >2cm in children is considered abnormal

    Acute Lymphadenopathy < 2 weeks duration

    Subacute Lymphadenopathy

    2-6 weeks duration Chronic Lymphadenopathy

    > 6 weeks duration

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    6/34

    Epidemiology

    0.6% annual incidence of unexplained

    adenopathy in the general population

    10% were referred to a subspecialist and 3.2 %

    required a biopsy and 1.1% had a malignancy

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    7/34

    Epidemiology

    Larsson et al. 38-45% of normal children have palpablecervical lymphadenopathy

    Park et al. 90% of children aged 4-8 have lymphadenopathy

    These masses can be mistaken for other local and systemicprocesses

    Congenital Masses

    Malignancies

    Local presentation of systemic disease

    Found by parents and caregivers and demand workup

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    8/34

    Physical Exam General

    Febrile or toxic appearing

    Skin

    Cellulitis, impetigo, rash

    HEENT

    Otitis, pharyngitis, teeth, and nasal cavity

    Neck Size

    Unilateral vs Bilateral

    Tender vs Nontender

    Mobile vs Fixed

    Hard vs Soft Lungs

    Consolidations suggesting TB

    Abdomen

    Hepatosplenomegaly

    Extremities Inguinal and Axillary adenopathy

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    9/34

    When to worry?

    Age

    Characteristics of the node

    Location of the node Clinical setting associated with

    lymphadenopathy

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    10/34

    Risk Factors to Keep in Mind Size Matters!!

    In one series of 213 adults with unexplained LAN who

    went on to biopsy

    LN 1.5x1.5 (2.25 cm2) - 38% malignancy

    Age Matters!! Age > 40, malignancy is more common

    (Age >40 = 4% vs Age < 40 = 0.4%)

    Location Matters!! Supraclavicular has the highest risk of Malignancy - est at

    90% in patients >40 and 25% in ages < 40

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    11/34

    Characteristics of the node

    ConsistencyHard/Firm vs Soft/Shotty; Fluctuant

    Mobile vs Fixed/Matted

    Tender vs Painless

    Clearly demarcated

    Size

    When to worry1.5-2cm in size

    Epitroclear nodes over 0.5cm; Inguinal over 1.5cm

    Duration and Rate of Growth

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    12/34

    EXAMINATION OF A LUMP

    Size

    Consistency: Hodgkins rubbery

    Tuberculosis matted

    Metastatic cancer craggy

    Calcified stony hard

    Tenderness: infectious mononucleosis, dentalsepsis, tonsilitis

    Fixation: malignancy

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    13/34

    Presentation of

    lymphadenopathy

    Unexplained

    lymphadenopathy

    3/4 presents with localized

    1/4 present withgeneralized

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    14/34

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    15/34

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    16/34

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    17/34

    Posterior Cervical LAN - Mono

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    18/34

    y -Scrofula

    Lymphatic spread ofM. tuberculosisas wellas atypical mycobacteria (M. scrofulaceum,

    MAI)

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    19/34

    Mycobacterial Lymphadenitis

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    20/34

    TB abscessas part of immune reconstitution syndrome

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    21/34

    Diagnostic Tests

    Fine needle aspiration biopsy (FNAB)

    Computed tomography (CT)

    Magnetic resonance imaging (MRI) Ultrasonography

    Radionucleotide scanning

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    22/34

    Role of Ultrasound (Ahuja et al.

    2005) No radiation exposure

    Good for following the progress of an abscess

    Differentiate Reactive vs Malignant nodes Reactive

    0.5cm)

    No echogenic hilus Cogaulative necrosis present

    High resistive index with low blood flow Extracapsular spread

    Sensitivity 95% and Specificity 83% for differentiating reactive vs metastaticlymph nodes

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    23/34

    Fine Needle Aspiration Biopsy

    Standard of diagnosis

    IndicationsAny neck mass that is not an obvious abscess

    Persistence after a 2 week course of antibiotics

    Small gauge needle Reduces bleeding

    Seeding of tumornot a concern No contraindications (vascular ?)

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    24/34

    Fine Needle Aspiration Biopsy

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    25/34

    Differential Diagnosis

    r t n

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    26/34

    a or at ogensHIV- related persistent generalized

    lymphadenopathy (PGL)

    Opportunistic infections tuberculous lymphadenitis, CMV,toxoplasmosis, infections with Nocardiaspecies, fungal infections(histoplasmosis, penicilliosis,cryptococcus, etc.)

    Reactive Lymphadenopathy pyomyositis, pyogenic skin infections,ear, nose, and throat (ENT) infections

    STIs syphilis, inguinal lymphadenopathy dueto donovanosis, chancroid orlymphogranuloma venereum (LGV)(see WHO or MSF guidelines)

    Malignancies lymphoma, Kaposis sarcoma

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    27/34

    Lymphadenitis

    Very common, especially within 1st decade

    Tender node with signs of systemic infection

    Directed antibiotic therapy with follow-up FNAB indications (pediatric)

    Actively infectious condition with no response

    Progressively enlarging

    Solitary and asymmetric nodal mass

    Supraclavicular mass (60% malignancy)

    Persistent nodal mass without active infection

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    28/34

    Generalized Lymphadenopathy

    Malignancylymphoma, leukemia, Kaposis sarcoma,metastases

    AutoimmuneSLE, RA, Sjogrens syndrome, Stills

    disease, Dermatomyositis InfectiousBrucellosis, Cat-scratch disease, CMV,

    HIV, EBV, Rubella, Tuberculosis, Tularemia, TyphoidFever, Syphilis, viral hepatitis, Pharyngitis

    OtherKawasakis disease, sarcoidosis, amyloidosis,lipid storage diseases, hyperthyroidism, necrotizinglymphadenitis, histiocytosis X, Castlemens disease

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    29/34

    Granulomatous lymphadenitis

    TypicalM. tuberculosis

    more common in adults Posterior triangle nodes

    Rarely seen in our population

    Usually responds to anti-TB medications May require excisional biopsy for further workup

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    30/34

    Drug Induced Lymphadenopathy

    Medications Phenytoin

    Pyrimethamine

    Allopurinol

    Phenylbutazone

    Isoniazide Immunizations

    Smallpox (historically)

    Live attenuated MMR

    DPT

    Poliomyelitis

    Typhoid fever

    **Usually self limited and resolves with cessation of medication orwith time in the case of immunization induced LAD

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    31/34

    Inguinal LAN

    STDs

    Tinea infections (pedis/cruris)

    Pelvic/Genital Malignancy

    (squamous/melanoma)

    Bubonic Plague? - was there an exposure?

    Lymphoma

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    32/34

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    33/34

    Terima kasih

  • 7/29/2019 Lymphadenopathy Uniba 18-1-13

    34/34

    Questions?